跳转至内容
Merck
CN
  • PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.

PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.

Nature communications (2014-12-06)
Davide Calebiro, Annette Hannawacker, Sandra Lyga, Kerstin Bathon, Ulrike Zabel, Cristina Ronchi, Felix Beuschlein, Martin Reincke, Kristina Lorenz, Bruno Allolio, Caroline Kisker, Martin Fassnacht, Martin J Lohse
摘要

We recently identified a high prevalence of mutations affecting the catalytic (Cα) subunit of protein kinase A (PKA) in cortisol-secreting adrenocortical adenomas. The two identified mutations (Leu206Arg and Leu199_Cys200insTrp) are associated with increased PKA catalytic activity, but the underlying mechanisms are highly controversial. Here we utilize a combination of biochemical and optical assays, including fluorescence resonance energy transfer in living cells, to analyze the consequences of the two mutations with respect to the formation of the PKA holoenzyme and its regulation by cAMP. Our results indicate that neither mutant can form a stable PKA complex, due to the location of the mutations at the interface between the catalytic and the regulatory subunits. We conclude that the two mutations cause high basal catalytic activity and lack of regulation by cAMP through interference of complex formation between the regulatory and the catalytic subunits of PKA.

材料
货号
品牌
产品描述

Sigma-Aldrich
单克隆抗-FLAG® M2 小鼠抗, clone M2, purified immunoglobulin (Purified IgG1 subclass), buffered aqueous solution (10 mM sodium phosphate, 150 mM NaCl, pH 7.4, containing 0.02% sodium azide)
Millipore
抗-FLAG® 兔抗, affinity isolated antibody, buffered aqueous solution